Resultados de la búsqueda 221-230 of 4198 for weakened immune system
Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...
Page 1.
Page 1. Page 2. Page 3. Page 4.
However, the FDA has allowed the use of this drug combination in this research study. A Study to Evaluate Immune-related Biomarkers for Pathological Response in ...
The purpose of this study is to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy ...
The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...
... Immune Phenotype in Operable Breast Cancer, the ENHANCE Study. Rochester, Minn. The purposes of this study are to evaluate whether pre-NAC peripheral blood ...
Other factors that affect prognosis and outcomes can include: Tumor location. Tumors deep in the brain are harder to remove and more likely to come back. Age at ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?